Abstract:A major pathway in hypertension pathogenesis involves direct activation of ANG II type 1 (AT1) receptors in the kidney, stimulating Na+ reabsorption. AT1 receptors in tubular epithelia control expression and stimulation of Na+ transporters and channels. Recently, we found reduced blood pressure and enhanced natriuresis in mice with cell-specific deletion of AT1 receptors in smooth muscle (SMKO mice). Although impaired vasoconstriction and preserved renal blood flow might contribute to exaggerated urinary Na+ excretion in SMKO mice, we considered whether alterations in Na+ transporter expression might also play a role; therefore, we carried out proteomic analysis of key Na+ transporters and associated proteins. Here, we show that levels of Na+-K+-2Cl- cotransporter isoform 2 (NKCC2) and Na+/H+ exchanger isoform 3 (NHE3) are reduced at baseline in SMKO mice, accompanied by attenuated natriuretic and diuretic responses to furosemide. During ANG II hypertension, we found widespread remodeling of transporter expression in wild-type mice with significant increases in the levels of total NaCl cotransporter, phosphorylated NaCl cotransporter (Ser71), and phosphorylated NKCC2, along with the cleaved, activated forms of the α- and γ-epithelial Na+ channel. However, the increases in α- and γ-epithelial Na+ channel with ANG II were substantially attenuated in SMKO mice. This was accompanied by a reduced natriuretic response to amiloride. Thus, enhanced urinary Na+ excretion observed after cell-specific deletion of AT1 receptors from smooth muscle cells is associated with altered Na+ transporter abundance across epithelia in multiple nephron segments. These findings suggest a system of vascular-epithelial in the kidney, modulating the expression of Na+ transporters and contributing to the regulation of pressure natriuresis.NEW & NOTEWORTHY The use of drugs to block the renin-angiotensin system to reduce blood pressure is common. However, the precise mechanism for how these medications control blood pressure is incompletely understood. Here, we show that mice lacking angiotensin receptors specifically in smooth muscle cells lead to alternation in tubular transporter amount and function. Thus, demonstrating the importance of vascular-tubular cross talk in the control of blood pressure.

Renal and cardiovascular sensory receptors and blood pressure regulation

Involvement of the Brain (Pro) Renin Receptor in Cardiovascular Homeostasis

A novel SCFA receptor, the microbiota, and blood pressure regulation

Olfactory receptor responding to gut microbiota-derived signals plays a role in renin secretion and blood pressure regulation

Short-Chain Fatty Acid Receptors and Blood Pressure Regulation: Council on Hypertension Mid-Career Award for Research Excellence 2021

Distinct roles for the kidney and systemic tissues in blood pressure regulation by the renin-angiotensin system.

Role of the Sympathetic Nervous System and Its Modulation in Renal Hypertension

Mechanosensitive Ion Channels in Blood Pressure-Sensing Baroreceptor Neurons.

The role of short-chain fatty acid on blood pressure regulation

Renal nerves in physiology, pathophysiology and interoception

Single-nucleus Sequencing Reveals Endothelial Cell-specific Dysregulation in the Kidney in Multiple Models of Hypertension

Role of Ectopic Olfactory Receptors in the Regulation of the Cardiovascular–Kidney–Metabolic Axis

Angiotensin II and AT1a Receptors in the Proximal Tubules of the Kidney: New Roles in Blood Pressure Control and Hypertension

Neural reflex regulation of arterial pressure in pathophysiological conditions: interplay among the baroreflex, the cardiopulmonary reflexes and the chemoreflex

Vascular control of kidney epithelial transporters

G protein-coupled receptor kinases in hypertension: physiology, pathogenesis, and therapeutic targets

New insights into the roles of olfactory receptors in cardiovascular disease

Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure.

Novel Smooth Muscle Ca2+-Signaling Nanodomains in Blood Pressure Regulation

Sympathetic transduction to blood pressure in patients with chronic kidney disease

Mineralocorticoid Receptors in Vascular Smooth Muscle: Blood Pressure and Beyond